قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ After Leaving Millions in Agony, The CDC Is Finally Clarifying Its Painkiller Restrictions

After Leaving Millions in Agony, The CDC Is Finally Clarifying Its Painkiller Restrictions



Fighting Words is Tonic's opinion column. Send pitches to tonic@vice.com

After three years of rising reports of harm to chronic pain patients – including dozens of accounts or suicide at people whose medications were cut off and hundreds of stories of increased disability — the Centers for Disease Control and Prevention (CDC) has issued a critical clarification of its 2016 Guideline for Prescribing Opioids for Chronic Pain.

Earlier this month, the Food and Drug Administration (FDA) also released an urgent warning clearly stating that physicians should not abruptly lose patients who are dependent on these medications. The agency also acknowledged the suicide risk associated with rapid tapering and other psychological and physical dangers for patients.

It's about time that these agencies addressed the widespread suffering caused by the crackdown on medical opioids that resulted from the predictable misapplication of the 201

6 guideline

Advocates are cautiously optimistic that the changes will start to restore balance to a policy that has ignored the plight of people with chronic pain, while focusing relentlessly on reducing the medical opioid supply.

“I am deeply appreciative that both the FDA and the CDC saw fit to speak now because it sets the table for all of us to have a serious conversation ”about both the harms and the benefits of the guideline, says Stefan Kertesz, a professor of preventive medicine at the University of Alabama at Birmingham. Kertesz was one of the key organizers of a letter recently sent to the CDC by the group Health Professionals for People in Pain, which requested just such a clarification.

The guideline urged doctors to be cautious about prescribing opioid doses higher than 90 morphine equivalents (to way to compare opioids or different strengths) and to generally avoid prescribing any opioids for chronic pain, if at all possible. Introduced in a country facing the worst overdose crisis in history, it was not surprising that what was meant by recommendations rapidly hardened into legal and insurance strictures.

Although the CDC says it did not intend to ban high-dose opioid Prescribing or force existing patients to quit, such results have been widely reported. Insurers, regulators, pharmacies, and state legislators have made the document — which was supposed to be flexible so that patients with complex needs would not be harmed — into a set of rigid rules without exceptions. And the guideline was also misapplied by these groups to include patients it was never intended to cover, such as people with cancer, those with post-surgical pain, and those taking medication to treat addiction.


Watch More from Vice News: [19659010] "I'm glad to see these points laid out so explicitly, although I will be those who say 'too little too late," says David Juurlink, head of the division of clinical pharmacology and toxicology at Sunnybrook Health Sciences Center in Toronto and a board member of one of the key organizations that pushed for the creation of the guideline, Physicians for Responsible Opioid Prescribing.
"To be fair to CDC, these same messages were clear from day one to anyone who actually bothered to read the guideline, "Juurlink adds." To the extent that the guideline caused problems for patients with chronic pain, it wasn't the recommendations themselves but rather their misapplication. "

One of the many misapplications was legal pressure on doctors from medical boards and criminal prosecutors, who often targeted physicians for deviation from the CDC's recommendations. Many such doctors reacted to forcing their patients to cut their doses or stop the medications altogether, affecting thousands of Americans. Even now, at least one state is considering requiring all medicaid patients with certain pain diagnoses to discontinuous opioids — regardless of whether they are benefiting from them.

But as the authors of the clarification (who were also the authors of the 2016 guideline) put it in a perspective piece in the New England Journal of Medicine :

Policies should allow clinicians to account for each patient's unique circumstances in making clinical decisions … An unintended consequence of expecting clinicians to mitigate risks or high-dose opioids is that rather than caring for patients receiving high doses or engaging and supporting patients in efforts to lose their

Clinicians might universally stop prescribing opioids, even in situations in which the benefits might outweigh their risks.

Kate Nicholson is a former federal prosecutor and pain patient who has herself required opioids in the careers. the past. In March, she and other advocates with CDC officials push for change, explaining how patients were being hurt

"I am delighted that the CDC and the FDA are taking action to protect patients," she says, "They basically we have been pretty much everything we asked. ”Added, however, that“ it is only beginning, given how broadly the guideline has been misapplied to every level of the healthcare system. ”

Kertesz agrees. "It is crucial for the institutional actors who have misapplied this guideline to take seriously that both the CDC and the FDA have ghosts in crystal-clear fashion," he says.

He added, "Quality metrics, public and private [insurance companies] that have weaponized the guideline by invoking its authority while disregarding what it said in plain English need to recalibrate. They have to do that urgently. ”

As someone who has covered the heartbreaking stories of people who have lost loved ones to suicide in the wake of these policies — and have spoken to dozens of patients who became or were less active after

Taking away needed medication from pain patients does nothing to fight addiction – and pretending that there is no role for opioids in the treatment of chronic pain. denies both science and clinical experience. The inexcusable commercial marketing of opioids to doctors has now not only people with addiction, but also two distinct groups of pain patients: those who benefit from opioids and are now being denied them, and those who do not benefit but are being lost

Lelena Peacock, a pain patient who has spent much of her time recently trying to help people who have become suicidal after losing access to medication, recently experienced and abrupt and involuntary loses herself.

I was abandoned from medical care like countless other patients on long-term opioids, ”she says. “We are now treated as patients, not patients. We're viewed as unmanageable liabilities that threaten the freedom and livelihoods of healthcare professionals across every point of the continuum of care…. The doctor / patient relationship has been almost completely destroyed. That relationship is now a punitive one. What took the CDC so long? ”

We have a long way to go before we can solve these problems – but at least the relevant agencies have finally come to exist and started to change course.

Sign up for our newsletter to get the best of Tonic delivered to your inbox.


Source link